Bioneer Corporation (KOSDAQ:064550)

Revenue by Product

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008	FY 2007	FY 2006	FY 2005
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009	Dec 31, 2008	Dec 31, 2007	Dec 31, 2006	Dec 31, 2005
Functional Lactic Acid Bacteria	268.72B
Functional Lactic Acid Bacteria Growth	20.58%
Genetic Reagents and Diagnostic Kits	10.73B
Genetic Reagents and Diagnostic Kits Growth	-12.06%
Oligo DNA / RNA	7.81B
Oligo DNA / RNA Growth	-14.30%
Genetic Research and Molecular Diagnostic Testing Equipment	2.26B
Genetic Research and Molecular Diagnostic Testing Equipment Growth	5.62%
Other	4.45B
Other Growth	-73.69%
Other	4.45B
Other Growth	-73.69%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008	FY 2007	FY 2006	FY 2005
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009	Dec 31, 2008	Dec 31, 2007	Dec 31, 2006	Dec 31, 2005
Other	276.11M
Other Growth	-7.26%
South Korea	275.62B
South Korea Growth	12.05%
Asia	12.83B
Asia Growth	24.53%
America	3.55B
America Growth	-19.06%
Europe	885.18M
Europe Growth	-56.96%
Africa	815.63M
Africa Growth	268.34%
Other	276.11M
Other Growth	-7.26%